基于NitraTh表位素的新抗原疫苗用于有效的瘤免疫疗法
Wanli Zhang1, Xupeiyao Shi1, Shitong Huang1
1Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.
Cancer immunology, immunotherapy : CII
|October 2, 2024
概括
这项研究引入了一种新的新抗原疫苗策略,使用"NitraTh表位"来绕过CD4+T细胞预测挑战. 这些疫苗有效地抑制瘤生长,并通过调节巨细胞来重新编程瘤微环境.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗开发 疫苗开发
背景情况:
- 新抗原疫苗是一种有前途的瘤免疫治疗策略.
- 准确预测CD4+T细胞表位仍然是疫苗设计的一个重大挑战.
- 目前的局限性阻碍了有效的新抗原疫苗的开发.
研究的目的:
- 开发一种独立于CD4+ T细胞表位预测的新型新抗原疫苗方法.
- 使用"NitraTh表位"策略设计瘤新抗原疫苗.
- 在临床前癌症模型中评估基于NitraTh表观素的疫苗的疗效.
主要方法:
- 开发新抗原疫苗,其中包含"NitraTh表位" (含p-nitrophenylalanine的辅助T细胞表位).
- 对新抗原特异性免疫反应的评估,包括针对低亲和度突变的免疫反应.
- 在H22细胞全移植和患者衍生异移植 (PDX) 肝癌小鼠模型中评估疫苗的疗效.
- 单细胞测序分析以调查免疫细胞调节,特别是巨细胞.
主要成果:
- 基于NitraTh表位素的疫苗成功引起了强大的新抗原特异性免疫反应.
- 在临床前肝癌模型中,瘤进展被显著抑制.
- 单细胞测序显示,疫苗可以重编程巨细胞,从而降低免疫抑制性前列腺素E2 (PGE2) 水平.
- 瘤微环境的调节是为了减少免疫抑制.
结论:
- 基于NitraTh表位的新抗原疫苗提供了一种新的方法,克服了预测的局限性.
- 这些疫苗显示出新抗原特异性免疫的强有力的激活.
- 该策略通过调节巨细胞,有效地减轻与瘤相关的免疫抑制.
- 这种方法为设计有效的瘤新抗原疫苗提供了一个新的范式.
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


